DK1073416T3 - Anvendelse af NO som anti-inflammatorisk middel - Google Patents

Anvendelse af NO som anti-inflammatorisk middel

Info

Publication number
DK1073416T3
DK1073416T3 DK98953702T DK98953702T DK1073416T3 DK 1073416 T3 DK1073416 T3 DK 1073416T3 DK 98953702 T DK98953702 T DK 98953702T DK 98953702 T DK98953702 T DK 98953702T DK 1073416 T3 DK1073416 T3 DK 1073416T3
Authority
DK
Denmark
Prior art keywords
inflammatory agent
inflammatory
agent
Prior art date
Application number
DK98953702T
Other languages
English (en)
Inventor
Warren M Zapol
Kenneth D Bloch
Anthony Rosenzweig
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26742873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1073416(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of DK1073416T3 publication Critical patent/DK1073416T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK98953702T 1997-10-21 1998-10-19 Anvendelse af NO som anti-inflammatorisk middel DK1073416T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6292697P 1997-10-21 1997-10-21
US08/971,003 US6656452B1 (en) 1997-10-21 1997-11-14 Use of inhaled NO as anti-inflammatory agent
PCT/US1998/022044 WO1999020251A1 (en) 1997-10-21 1998-10-19 Use of inhaled no as anti-inflammatory agent

Publications (1)

Publication Number Publication Date
DK1073416T3 true DK1073416T3 (da) 2009-03-09

Family

ID=26742873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953702T DK1073416T3 (da) 1997-10-21 1998-10-19 Anvendelse af NO som anti-inflammatorisk middel

Country Status (13)

Country Link
US (2) US6656452B1 (da)
EP (1) EP1073416B1 (da)
JP (1) JP2003532615A (da)
AR (1) AR015973A1 (da)
AT (1) ATE421874T1 (da)
AU (1) AU751853B2 (da)
CA (1) CA2309038C (da)
CY (1) CY1110228T1 (da)
DE (1) DE69840526D1 (da)
DK (1) DK1073416T3 (da)
ES (1) ES2319240T3 (da)
PT (1) PT1073416E (da)
WO (1) WO1999020251A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US20030070674A1 (en) * 2001-10-12 2003-04-17 Bryan Perry Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
AU2003265239A1 (en) * 2002-05-22 2003-12-19 Virginia Commonwealth University Protective effects of pde-5 inhibitors
DE10327000A1 (de) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Xenonhaltiges Spasmolytikum
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
EP1653978B1 (en) 2003-07-09 2020-06-03 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Use of nitrite salts for the treatment of cardiovascular conditions
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
US7829097B2 (en) * 2006-02-06 2010-11-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of HMGB1 for protection against ischemia reperfusion injury
WO2008063868A2 (en) * 2006-11-07 2008-05-29 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
CA2685446A1 (en) 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
WO2010049423A1 (en) * 2008-10-27 2010-05-06 Life Sciences Research Partners Vzw Effects of nitric oxide inhalation on long-term myocardial reperfusion injury
TWI626057B (zh) 2009-06-09 2018-06-11 普龍製藥有限責任公司 血紅素組成物
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
EP2645860A4 (en) * 2010-12-03 2014-07-09 Geno Llc NITROGEN OXIDE TREATMENTS
US9573110B2 (en) 2011-10-03 2017-02-21 NitricGen, Inc. Apparatus and method for generating nitric oxide in controlled and accurate amounts
CN104159591A (zh) 2011-11-07 2014-11-19 通用医疗公司 红细胞的处理
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2023190532A1 (ja) * 2022-03-29 2023-10-05 康太郎 木田 横紋筋融解症を治療するための医薬組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
CA2175467A1 (en) 1993-11-02 1995-05-11 David A. Wink, Jr. Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
US5521191A (en) 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
JP2000510448A (ja) 1996-04-05 2000-08-15 ザ ジェネラル ホスピタル コーポレーション 異常ヘモグロビン症の治療
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation

Also Published As

Publication number Publication date
AU1101299A (en) 1999-05-10
EP1073416A4 (en) 2004-07-07
AU751853B2 (en) 2002-08-29
WO1999020251A1 (en) 1999-04-29
EP1073416A1 (en) 2001-02-07
US6656452B1 (en) 2003-12-02
ES2319240T3 (es) 2009-05-05
CA2309038C (en) 2009-04-21
CY1110228T1 (el) 2015-01-14
US20040096523A1 (en) 2004-05-20
DE69840526D1 (de) 2009-03-19
PT1073416E (pt) 2009-03-17
ATE421874T1 (de) 2009-02-15
CA2309038A1 (en) 1999-04-29
EP1073416B1 (en) 2009-01-28
JP2003532615A (ja) 2003-11-05
US6811768B2 (en) 2004-11-02
AR015973A1 (es) 2001-05-30

Similar Documents

Publication Publication Date Title
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
DK1335725T3 (da) Anvendelse af CCI-779 som et antineoplastisk middel
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
DK0975778T3 (da) Anvendelse af glyphostat-resistende majslinier
DK1288206T3 (da) Substituerede benzensulfonamidderivater som prolægemidler af COX-2-inhibitorer
NO20020275D0 (no) Imidazoimidazoler og -triazoler som anti-inflammatoriske midler
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
NO20012562D0 (no) Ikke-steroidale antiinflammatoriske midler
PT966430E (pt) Compostos anti-inflamatorios
ATE284385T1 (de) Sulfonamidderivate
DK0908449T3 (da) Fremstilling af carotenoider
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
DK1066029T3 (da) Suspension af peroralt aktivt middel
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK0911311T3 (da) Fremstilling af lycopenmetabolitter
DK0746979T3 (da) Anvendelse af pyrrolforbindelser som antibegroningsmidler
NO20001196D0 (no) Nootropisk middel
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DK1011689T3 (da) Anvendelse af 9a-azalider som veterinære antimikrobielle midler
DK1102747T3 (da) Krystalformer af osenetant
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater